Discover the Expert Speaker Faculty

Allison Webb

Senior Program Manager

Blueprint Medicine

Amber Bifolck Fisher

Senior Clinical Research Manager, Expanded Access & Investigator Initiated Study Programs

Kura Oncology

Anh Tran

Executive Director, Clinical Operations Late Phase TA Lead

Alexion Pharmaceuticals

Annie Drelles

Senior Director & Head, Office of Medical Access, Global Oncology Medical Affairs

Daiichi Sankyo

Becket Feierbach

Managed Access Programs Lead

Gilead Sciences

Bethany Bearden

Associate Director of Early Access Programs

Blueprint Medicine

Brent Kreider

President

Biomed Valley Discoveries

Deborah Nicodemos

Managed Access & Program Lead

Novartis

Debra Litwak

Senior Director, Global Medical Affairs, Initiated Trials & Compassionate Use Programs Investigator

BeiGene

Dennis Akkaya

Chief Commercial Officer

myTomorrows

Harpreet Ram

Founder & Executive Director

GARDaccess

Helen Kellar-Wood

Global Head of Patient Access

Bristol Myers Squibb

Jasmina Ahrens

Global Lead, Rare Humanitarian Operations

Sanofi

Jen Abovich

Senior Manager, Global Oncology Expanded Access

Takeda

Joseph Muenzer

Professor - Pediatric & Stakeholder Engagement University of North Carolina

Chapel Hill

Kirsten Hoyer

Associate Director

Ascendis Pharma

Laura Carr

Executive Director & Head, GOMA Clinical Trial Management, Resources, Operations, & Governance

Daiichi Sankyo

Laura Gagnon

Director, Global Oncology Expanded Patient Access Programs

Takeda

Lea Ann McNee

Director, Communication & Stakeholder Engagement

Reagan-Udall Foundation for the FDA

Leigh-Ann Durant

Head of North America Medical Governance, Chief Medical Officer Governance & Operations

EMD Serono

Michael Bethel

Global Head of Access Mechanisms

Biogen

Michael Wrigglesworth

Vice President, Programs Operations

The Max Foundation

Michelle Clausen

Senior Director, Expanded Access Enterprise Medical Community

Pfizer

Nicole Garmon

Director, Clinical Supply Strategy & Management

Pfizer

Safwan Kezbor

Senior Director, Medical & Clinical Development

Shionogi

Sarah Gilmore

Director Managed Access Programs, Global Medical Affairs

Gilead Sciences

Simon Morgan

Team Lead, Qualifies Person

Pfizer